The pathophysiology, medical management and dental implications of fragile X, Rett, and Prader-Willi syndromes.

Journal of the California Dental Association

Volumn 31, Issue 9, 2003, Pages 693-702

  Friedlander, Arthur H ^a   Yagiela, John A ^a   Paterno, Victoria I ^a   Mahler, Michael E ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CENTRAL STIMULANT AGENT; NEUROLEPTIC AGENT;

CHEMICALLY INDUCED DISORDER; DENTAL CARE; DENTAL CARIES; DRUG INTERACTION; FRAGILE X SYNDROME; HUMAN; MENTAL DEFICIENCY; MOUTH DISEASE; PATHOPHYSIOLOGY; PRADER WILLI SYNDROME; RETT SYNDROME; REVIEW;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DENTAL CARE FOR CHRONICALLY ILL; DENTAL CARIES; DRUG INTERACTIONS; FRAGILE X SYNDROME; HUMANS; MENTAL RETARDATION; MOUTH DISEASES; PRADER-WILLI SYNDROME; RETT SYNDROME;

EID: 0642375625     PISSN: 10432256     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)